Cargando…

Circulating renin‐angiotensin‐aldosterone system activity in cats with systemic hypertension or cardiomyopathy

BACKGROUND: Activity of the circulating renin‐angiotensin‐aldosterone system (RAAS) has not been comprehensively characterized in cats with systemic hypertension (SH) or cardiomyopathy (CM), and the effects of furosemide or amlodipine treatment on the RAAS have not been fully evaluated in cats. HYPO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ward, Jessica L., Guillot, Emilie, Domenig, Oliver, Ware, Wendy A., Yuan, Lingnan, Mochel, Jonathan P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	SMALL ANIMAL
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151484/ https://www.ncbi.nlm.nih.gov/pubmed/35285549 http://dx.doi.org/10.1111/jvim.16401

Ejemplares similares

Suspected primary hyperreninism in a cat with malignant renal sarcoma and global renin‐angiotensin‐aldosterone system upregulation
por: Evans, Jeremy, et al.
Publicado: (2021)

The renin‐angiotensin‐aldosterone system and its suppression
por: Ames, Marisa K., et al.
Publicado: (2019)

The Renin‐Angiotensin‐Aldosterone System in Greyhounds and Non‐Greyhound Dogs
por: Martinez, J., et al.
Publicado: (2017)

Renin‐angiotensin aldosterone profile before and after angiotensin‐converting enzyme‐inhibitor administration in dogs with angiotensin‐converting enzyme gene polymorphism
por: Adin, Darcy, et al.
Publicado: (2020)

Influence of sex on renin‐angiotensin‐aldosterone system metabolites and enzymes in Doberman Pinschers
por: Adin, Darcy B., et al.
Publicado: (2022)

Dose–response of benazepril on biomarkers of the classical and alternative pathways of the renin–angiotensin–aldosterone system in dogs
por: Sotillo, Samantha, et al.
Publicado: (2023)

Changes in renin‐angiotensin‐aldosterone system during cardiac remodeling after mitral valvuloplasty in dogs
por: Cheng, Chieh‐Jen, et al.
Publicado: (2022)

Effect of calcifediol supplementation on renin‐angiotensin‐aldosterone system mediators in dogs with chronic kidney disease
por: Miller, Matthew, et al.
Publicado: (2022)

Effect of spironolactone and benazepril on furosemide‐induced diuresis and renin‐angiotensin‐aldosterone system activation in normal dogs
por: Adin, Darcy, et al.
Publicado: (2021)

Prevalence of aldosterone breakthrough in dogs receiving renin‐angiotensin system inhibitors for proteinuric chronic kidney disease
por: Ames, Marisa K., et al.
Publicado: (2022)

Characterization of the intrarenal renin‐angiotensin system in cats with naturally occurring chronic kidney disease
por: Lourenço, Bianca N., et al.
Publicado: (2022)

The classical and alternative circulating renin‐angiotensin system in normal dogs and dogs with stage B1 and B2 myxomatous mitral valve disease
por: Hammond, Hillary H., et al.
Publicado: (2023)

Vitamin D status in cats with cardiomyopathy
por: Ware, Wendy A., et al.
Publicado: (2020)

Role of electrolyte concentrations and renin‐angiotensin‐aldosterone activation in the staging of canine heart disease
por: Adin, Darcy, et al.
Publicado: (2019)

Retrospective evaluation of a dose‐dependent effect of angiotensin‐converting enzyme inhibitors on long‐term outcome in dogs with cardiac disease
por: Ward, Jessica L., et al.
Publicado: (2021)

Evaluation of Renin–Angiotensin–Aldosterone System Components and Enzymes in Systemically Hypertensive Cats Receiving Amlodipine
por: Adin, Darcy, et al.
Publicado: (2023)

Plasma renin activity and aldosterone concentration in dogs with acquired portosystemic collaterals
por: Sakamoto, Yumi, et al.
Publicado: (2019)

Circulating neutrophil extracellular traps in cats with hypertrophic cardiomyopathy and cardiogenic arterial thromboembolism
por: Li, Ronald H. L., et al.
Publicado: (2023)

Retrospective evaluation of risk factors for development of kidney injury after parenteral furosemide treatment of left‐sided congestive heart failure in dogs
por: Giorgi, Maria E., et al.
Publicado: (2022)

Retrospective study of aldosterone and progesterone secreting adrenal tumors in 10 cats
por: Harro, Cailin C., et al.
Publicado: (2021)

Long‐term incidence and risk of noncardiovascular and all‐cause mortality in apparently healthy cats and cats with preclinical hypertrophic cardiomyopathy
por: Fox, Philip R., et al.
Publicado: (2019)

Beyond the Circulating Renin–Angiotensin Aldosterone System
por: De Mello, Walmor C.
Publicado: (2014)

Retrospective evaluation of the safety and tolerability of pimobendan in cats with obstructive vs nonobstructive cardiomyopathy
por: Ward, Jessica L., et al.
Publicado: (2020)

Effect of angiotensin receptor blockers and angiotensin‐converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in cats with heart disease
por: Huh, Terry, et al.
Publicado: (2020)

Symmetric Dimethylarginine in Cats with Hypertrophic Cardiomyopathy and Diabetes Mellitus
por: Langhorn, R., et al.
Publicado: (2017)

Speckle tracking echocardiography in cats with preclinical hypertrophic cardiomyopathy
por: Spalla, Ilaria, et al.
Publicado: (2019)

Natural history of hypertrophic cardiomyopathy in cats from rehoming centers: The CatScan II study
por: Novo Matos, Jose, et al.
Publicado: (2022)

International collaborative study to assess cardiovascular risk and evaluate long‐term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study
por: Fox, Philip R., et al.
Publicado: (2018)

Diagnostic utility of cardiac troponin I in cats with hypertrophic cardiomyopathy
por: Hori, Yasutomo, et al.
Publicado: (2018)

Cardiac extracellular volume fraction in cats with preclinical hypertrophic cardiomyopathy
por: Fries, Ryan C., et al.
Publicado: (2021)

Echocardiographic Assessment of Right Ventricular Size and Function in Cats With Hypertrophic Cardiomyopathy
por: Visser, L.C., et al.
Publicado: (2017)

Detection of congestive heart failure by Doppler echocardiography in cats with hypertrophic cardiomyopathy
por: Rohrbaugh, Michelle N., et al.
Publicado: (2020)

Clinical, epidemiological and echocardiographic features and prognostic factors in cats with restrictive cardiomyopathy: A retrospective study of 92 cases (2001‐2015)
por: Chetboul, Valérie, et al.
Publicado: (2019)

Role of the Renin–Angiotensin–Aldosterone System in Dystrophin-Deficient Cardiomyopathy
por: Rodriguez-Gonzalez, Moises, et al.
Publicado: (2020)

Biomarker changes with systolic anterior motion of the mitral valve in cats with hypertrophic cardiomyopathy
por: Seo, Joonbum, et al.
Publicado: (2020)

Evaluation of point‐of‐care thoracic ultrasound and NT‐proBNP for the diagnosis of congestive heart failure in cats with respiratory distress
por: Ward, Jessica L., et al.
Publicado: (2018)

Mitral Annular Plane Systolic Excursion and Tricuspid Annular Plane Systolic Excursion in Cats with Hypertrophic Cardiomyopathy
por: Spalla, I., et al.
Publicado: (2017)

Associations among echocardiography, cardiac biomarkers, insulin metabolism, morphology, and inflammation in cats with asymptomatic hypertrophic cardiomyopathy
por: van Hoek, Ingrid, et al.
Publicado: (2020)

Systolic third sound associated with systolic anterior motion of the mitral valve in cats with obstructive hypertrophic cardiomyopathy
por: Saponaro, Vittorio, et al.
Publicado: (2023)

Quantification of Urine Elimination Behaviors in Cats with a Video Recording System
por: R. Dulaney, D., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0qlh91uhsn7v8q8n17so6j3sl2